PeptiCRAd – Flexible Peptide Delivery Platform for Therapeutic Cancer (Neoantigen) Vaccines
Time: 4:00 pm
day: Day One
Details:
• Reviewing how the safety and efficacy of these vaccine modalities remains unclear in certain cancer patients
• Addressing the complex manufacturing process and regulatory aspects
• Developing neoantigen vaccines based on peptides and viral adjuvants
